We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$144M
Cap. Flow %
3.24%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
4.6 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.84%
2 Technology 15.96%
3 Healthcare 9.75%
4 Financials 7.52%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EYE icon
3401
National Vision
EYE
$1.4B
$141 ﹤0.01%
+11
New +$130
2025 Q1
0 quarters
METC icon
3402
Ramaco Resources Class A
METC
$531M
$140 ﹤0.01%
17
-752
-98% -$7K
2024 Q3
2 quarters
CMRC icon
3403
Commerce.com Inc Series 1
CMRC
$295M
$138 ﹤0.01%
+24
New +$152
2025 Q1
0 quarters
TEAD icon
3404
Teads Holding Co
TEAD
$40.8M
$138 ﹤0.01%
+37
New +$209
2025 Q1
0 quarters
SEM icon
3405
DELISTED
Select Medical
SEM
$134 ﹤0.01%
8
– –
2023 Q4
5 quarters
MBI icon
3406
MBIA
MBI
$224M
$129 ﹤0.01%
26
-63
-71% -$390
2023 Q4
5 quarters
ME icon
3407
DELISTED
23andMe Holding Co
ME
$129 ﹤0.01%
175
+125
+250% +$313
2021 Q2
15 quarters
GOLD icon
3408
Gold.com Inc
GOLD
$1.15B
$127 ﹤0.01%
+5
New +$138
2025 Q1
0 quarters
MRC icon
3409
DELISTED
MRC Global
MRC
$126 ﹤0.01%
11
– –
2022 Q3
10 quarters
CAPR icon
3410
Capricor Therapeutics
CAPR
$423M
$123 ﹤0.01%
13
– –
2024 Q4
1 quarter
GOGO icon
3411
Gogo Inc
GOGO
$305M
$121 ﹤0.01%
14
-52
-79% -$407
2024 Q4
1 quarter
IMVT icon
3412
Immunovant
IMVT
$5.68B
$120 ﹤0.01%
7
-31
-82% -$648
2024 Q4
1 quarter
ABCB icon
3413
Ameris Bancorp
ABCB
$5.35B
$115 ﹤0.01%
2
– –
2024 Q2
3 quarters
ISTR icon
3414
Investar Holding Corp
ISTR
$395M
$113 ﹤0.01%
6
– –
2022 Q4
9 quarters
SANA icon
3415
Sana Biotechnology
SANA
$742M
$113 ﹤0.01%
67
-113
-63% -$316
2024 Q4
1 quarter
SCM icon
3416
Stellus Capital Investment Corp
SCM
$206M
$112 ﹤0.01%
8
– –
2024 Q4
1 quarter
XME icon
3417
State Street SPDR S&P Metals & Mining ETF
XME
$4.02B
$112 ﹤0.01%
2
– –
2020 Q3
18 quarters
ELME icon
3418
Elme Communities
ELME
$156M
$111 ﹤0.01%
6
-1
-14% -$16
2023 Q2
7 quarters
DFTX icon
3419
Definium Therapeutics
DFTX
$4.6B
$111 ﹤0.01%
19
– –
2022 Q2
11 quarters
TDUP icon
3420
ThredUp
TDUP
$309M
$111 ﹤0.01%
46
– –
2023 Q1
8 quarters
ANGI icon
3421
Angi Inc
ANGI
$262M
$108 ﹤0.01%
+7
New +$119
2025 Q1
0 quarters
VERV icon
3422
DELISTED
Verve Therapeutics
VERV
$105 ﹤0.01%
23
– –
2024 Q3
2 quarters
GSAT icon
3423
Globalstar
GSAT
$10.7B
$104 ﹤0.01%
5
-6
-55% -$145
2024 Q4
1 quarter
EGHT icon
3424
8x8 Inc
EGHT
$299M
$100 ﹤0.01%
50
-69
-58% -$178
2024 Q3
2 quarters
KREF icon
3425
KKR Real Estate Finance Trust
KREF
$350M
$97 ﹤0.01%
9
– –
2022 Q4
9 quarters

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.